Accra, May 17, GNA-Mr Kwasi Poku Boateng, Country Manager, United States Pharmacopeia (USP) Ghana said his establishment was poised to support the objective of the African Medicines Regulatory Harmonisation
He said USP Ghana was working with NEPAD to champion the implementation of the continental medicines quality forum by developing curricula that enhances the competence of regulatory professionals and provide technical support in the medicines regulatory harmonization efforts on the continent.
Mr Boateng said this at a cocktail event to mark its fifth milestone celebration in Accra affirming that the future looked splendid.
USP formerly known as Centre for Pharmaceutical Advancement and Training (CePAT) has trained more than 320 manufacturers and regulators from over 40 African countries with added scope in testing, providing consultancy services as well as innovation and regional leadership know-how’s.
He said its pilot Pharmaceutical Development and Regulatory Science programme designed for University students to bridge the gap between academia and industry has been successful and ready for scaling up to benefit more Universities.
The Country Manager said it would maintain its commitment to building capacity in pharmaceutical quality assurance and control and expand its focus to new areas of pharmaceutical regulations in biologics and medical devices.
“We have also repackaged our short courses to include but not limited to the following – Quality Management Systems, Equipment Preventive Maintenance which will now include pre -Acquisition, Acquisition and post – Acquisition elements, and Microbial Testing.”
Dr Benjamin Botwe, Rector, Ghana College of Pharmacists said USP Ghana is assisting to reverse the proliferation of substandard and falsified medicines leading to therapeutic failures and drug resistance, a major cause of many deaths and disability in developing countries.
“USP Ghana has trained regulatory officials and researchers from almost every country in Africa and has therefore become a major game changer in the industry.”
Doubling as the President of the Pharmaceutical Society of Ghana, he praised the US Pharmacopeia Convention for this initiative, which had made tremendous impact in the pharmaceutical industry, regulatory systems and medicine quality control not only in Ghana but throughout Sub Saharan Africa.
Mr Hermes Van Der Lee, Senior Vice President, USP-Global Laboratory Operations said the design of USP was to sequence and coordinate approaches to build local capacity for self-reliance as being demonstrated.
Mr Karim Smine, Director, USP-Global Public Health Africa was elated that USP Ghana is manned solely by Ghanaian professionals who are impacting the continent positively.
Mr Yaw Agyei-Henaku, Head of Quality Assurance, USP Ghana said the entity’s anniversary gift was receiving the World Health Organisation (WHO) Pre-Qualification approval of its laboratory to test pharmaceutical products and recognized globally, though it had the ISO /IEC17025 approval already, which is an international standard for competence for pharmaceutical quality control analyst certification for laboratory.
He said USP Ghana is collaborating with the Food and Drugs Authority in field testing the large volumes of products for quality assurance and control in line with its mission of augmenting the knowledge gap for the manufacture and regulation of medicines and provide third party testing for critical essential medicines in Africa.